Showing results (191-200 of 219) with videos related to

Sort By:
Pageof 22
Pharmacotherapy|October 18, 2000
Pharmacokinetics of gemcitabine and 2',2'-difluorodeoxyuridine in a patient with ascitesB J Delauter, R K Ramanathan, M J Egorin, et al.
Clinical Immunology (Orlando, Fla.)|July 24, 2001
Simultaneous presence of mucous membrane pemphigoid and pemphigus vulgaris: molecular characterization of both autoantibodiesN Sami, K C Bhol, E H Beutner, et al.
Leukemia & Lymphoma|June 1, 1993
Phase II clinical trial of fludarabine in chronic lymphocytic leukemia on a weekly low-dose scheduleA Kemena, S O'Brien, H Kantarjian, et al.
Seminars in Oncology|August 1, 1995
Difluorodeoxyguanosine: cytotoxicity, metabolism, and actions on DNA synthesis in human leukemia cellsV Gandhi, S Mineishi, P Huang, et al.
Leukemia|June 1, 1995
Fludarabine plus doxorubicin in previously treated chronic lymphocytic leukemiaL E Robertson, S O'Brien, H Kantarjian, et al.
Leukemia & Lymphoma|March 18, 2000
Prediction of prognosis following fludarabine used as secondary therapy for chronic lymphocytic leukemiaM J Keating, T L Smith, S Lerner, et al.
Family Process|August 11, 2017
Family Profiles of Cohesion and Parenting Practices and Latino Youth AdjustmentMayra Y Bámaca-Colbert, Melinda Gonzales-Backen, Carolyn S Henry, et al.
Cancer Research|April 1, 1995
Cytotoxicity, metabolism, and mechanisms of action of 2',2'-difluorodeoxyguanosine in Chinese hamster ovary cellsV Gandhi, S Mineishi, P Huang, et al.
The American Journal of Medicine|September 1, 1986
Phase I-II clinical and pharmacologic studies of high-dose cytosine arabinoside in refractory leukemiaH M Kantarjian, E H Estey, W Plunkett, et al.
Leukemia|October 1, 1996
Clinical and laboratory studies of 2-chlorodeoxyadenosine +/- cytosine arabinoside for relapsed or refractory acute myelogenous leukemia in adultsS M Kornblau, V Gandhi, H M Andreeff, et al.
Pageof 22